Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00318344
Status:
COMPLETED
Last Update Posted:
2010-02-02
First Post:
2006-04-24
Brief Title:
Evaluation of Atuna Racemosa Toxicity
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Evaluation of Atuna Racemosa Toxicity
Status:
COMPLETED
Status Verified Date:
2010-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
For thousands of years people in the South Pacific have used Atuna racemosa extract as a topical anti-inflammatory We the researchers at the Mayo Clinic have shown this extract to also have antibacterial properties While this extract has been used for decades in the South Pacific a controlled clinical trial to evaluate toxicity has never been performed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None